Prostate Adenocarcinoma With Neuroendocrine Differentiation

specific

An invasive prostate adenocarcinoma characterized by the presence of malignant cells that exhibit neuroendocrine differentiation.

11

Centers

11

Active Trials

Cancer Funding

Top Centers for Prostate Adenocarcinoma With Neuroendocrine Differentiation(11)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
54.5
2
NCI Comprehensive
Active Research Program
54.5
3
NCI Comprehensive
Active Research Program
54.5
454.5
5
NCI Comprehensive
Active Research Program
54.5
6
NCI Comprehensive
Active Research Program
54.5
7
NCI Comprehensive
Active Research Program
54.5
8
NCI Comprehensive
Active Research Program
54.5
9
Active Research Program
54.5
10
NCI Comprehensive
Active Research Program
54.5
11
Active Research Program
54.5

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →